AGP Executive Report
Last update: 11 hours agoFood Safety: Maharashtra has banned loose spice sales after tests found carcinogenic dyes, including Sudan dye and lead chromate; manufacturers face inspections and possible prosecution. Drug Enforcement: Punjab says it seized medicines worth ₹20.64 crore and suspended 520 chemists’ licences during a crackdown on violations. Infectious Disease: Mumbai doctors report more severe malaria cases, including critical illness linked to vivax malaria, and warn patients against delaying care or self-medicating. Hospital Access: Delhi’s LNJP Hospital has added MRI and CT scanners expected to double scanning capacity, easing waits that reached up to two to three years. Mental Health: A new report highlights long delays in care: more than half of patients waited at least a year for professional support, while 56% reported thoughts of self-harm before seeking help. Drug Innovation: The government is offering startups up to ₹50 crore for drug discovery, but experts say India also needs stronger clinical-trial infrastructure. Medicine Affordability: Novo Nordisk has cut the price of its growth hormone therapy Norditropin FlexPro by up to 35%.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
